CHINGCHENG ATTORNEYS AT LAW-law firm,lawyer
Team Intro
Team Intro
About Us
Attorneys
Intellectual property research
Expertise & Services
Expertise & Services
Legal Expertise
IP Expertise
Key Clients
Key Clients
Articles
Articles
Taiwan Know-How
Real-Time Upda
Patent analysis
Service Locations
Service Locations
Contact Us
Contact Us
Patent analysis opinions
首頁
> Patent analysis opinions
Article
Taiwan Know-How for Foreigners
Real-Time Update
Patent analysis opinions
Patent analysis opinions
UCB’s “Zilucoplan” has been approved for marketing in China
release:2025/10/21
FDA Approves the World’s First PDE4B Inhibitor Nerandomilast for Idiopathic Pulmonary Fibrosis
release:2025/10/21
AT&T and Nokia Win Patent Infringement Lawsuit
release:2025/10/21
InnoCare’s “Orelabrutinib” has been approved in Singapore
release:2025/09/29
xAI Wins Court Order Blocking Former Engineer from Sharing AI Technology with OpenAI
release:2025/09/29
Novartis Atrasentan Hydrochloride Tablets Approved in China
release:2025/09/29
The world’s first generic Dulaglutide has been approved for marketing in China
release:2025/09/07
Bayer Submits NDA for HER2-Targeted Therapy BAY 2927088 in China
release:2025/09/07
SUN PHARMA LAUNCHES HAIR LOSS DRUG IN THE UNITED STATES AFTER PATENT DISPUTE SETTLEMENT WITH INCYTE
release:2025/09/07
Lululemon Sues Costco Over Alleged Counterfeit Sales
release:2025/09/07
June 2025 Newsletter - Halozyme Files Patent Infringement Lawsuit against Merck over Subcutaneous Keytruda Formulation
release:2025/06/25
June 2025 Newsletter - Merck's Oral PCSK9 Inhibitor Achieves Breakthrough Progress in Phase III Clinical Trials
release:2025/06/25
1
2
3
TOP
回首頁
電話